13 WTHR - Indianapolis News |Acadia 3Q loss narrows on revenue boost

Acadia 3Q loss narrows on revenue boost

Posted: Updated:

SAN DIEGO (AP) - Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners.

The development-stage biopharmaceutical company lost $8.7 million, or 23 cents per share, compared with a loss of $15.6 million, or 42 cents per share, during the same period a year prior. Revenue surged to $2.4 million from $282,000, mainly on the company's collaboration with Biovail.

Analysts expected a loss of 24 cents per share.

The company is working with Biovail on pimavanserin as a potential Parkinson's disease treatment and schizophrenia therapy. They've been partners since May.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Powered by WorldNow
All content © Copyright 2002 - 2010 WorldNow and WTHR. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.It is the policy of The Dispatch Broadcast Group to provide equal employment opportunity to all qualified individuals without regard to their race, color, religion, national origin, age, sex, marital status, disability, military status, citizenship or any other legally-protected status in accordance with applicable local, state and federal law. Jobs at WTHR EEO Public File Report